Showing results (111-120 of 354) with videos related to
Sort By:
Pageof 36
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Altered major histocompatibility complex proteins and peptides for the induction of tolerance after organ transplantationC Shih-Chueh, B D KahanJournal of Clinical Pharmacology|May 1, 1997
Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administrationJ J Zimmerman, B D KahanJournal of Nephrology|July 3, 1998
Surgical complications of kidney transplantationZ T Beyga, B D KahanTransplantation Proceedings|June 1, 1990
Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassayK L Napoli, B D KahanCancer Research|May 1, 1985
Extraction of a murine tumor-specific antigen from cells and plasma membranes using 1-butanol: augmentation of antigen yield by colchicineS J LeGrue, B D KahanJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1975
Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotectionN R Pellis, B D KahanClinics in Laboratory Medicine|September 1, 1991
Considerations for monitoring cyclosporine in transplant recipientsK L Napoli, B D KahanTransplantation|February 1, 1987
Thin-layer chromatographic detection of cyclosporine and its metabolites in whole blood using rhodamine B and alpha-cyclodextrinT R Roesel, B D KahanKidney International|July 28, 2006
The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity?R J Knight, B D KahanArchives of Surgery (Chicago, Ill. : 1960)|February 1, 1984
Phagocytic cell function in response to immunosuppressive therapyD B Drath, B D KahanPageof 36